Skip to main content
. Author manuscript; available in PMC: 2007 Oct 22.
Published in final edited form as: Lancet. 2007 Mar 24;369(9566):1016–1026. doi: 10.1016/S0140-6736(07)60461-9

Table 7.

Incremental cost-effectiveness ratios—cost per seizure avoided

Cost (£) Seizures Incremental cost (£) Incremental
seizures avoided
Incremental
cost-effectiveness ratio
(£ per seizure avoided)
Valproate 1136  44·1 .. .. ..
Topiramate 1568  75·1 432 −31·0 Dominated
Lamotrigine 1761 120·9 193 −45·8 Dominated